These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28223842)

  • 1. Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims.
    Margolis JM; Princic N; Smith DM; Abraham L; Cappelleri JC; Shah SN; Park PW
    J Pain Res; 2017; 10():327-339. PubMed ID: 28223842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Impact of Adherence to Pain Treatment Guidelines in Chronic Pain Patients.
    Margolis JM; Princic N; Smith DM; Abraham L; Cappelleri JC; Shah SN; Park PW
    Pain Med; 2019 Oct; 20(10):1907-1918. PubMed ID: 31034040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia.
    Johnston SS; Udall M; Alvir J; McMorrow D; Fowler R; Mullins D
    Pain Med; 2014 Apr; 15(4):562-76. PubMed ID: 24433487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
    Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
    J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pregabalin step therapy policy among medicare advantage beneficiaries.
    Suehs BT; Louder A; Udall M; Cappelleri JC; Joshi AV; Patel NC
    Pain Pract; 2014 Jun; 14(5):419-26. PubMed ID: 23701733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns.
    Hartsfield CL; Korner EJ; Ellis JL; Raebel MA; Merenich J; Brandenburg N
    Popul Health Manag; 2008 Dec; 11(6):317-28. PubMed ID: 19108647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
    Udall M; Harnett J; Mardekian J
    J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center.
    Mearis M; Shega JW; Knoebel RW
    J Pain Symptom Manage; 2014 Sep; 48(3):451-8. PubMed ID: 24439844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.
    Margolis JM; Cao Z; Onukwugha E; Sanchez RJ; Alvir J; Joshi AV; Mullins CD
    Am J Manag Care; 2010 Jun; 16(6):447-56. PubMed ID: 20560688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia.
    Halpern R; Shah SN; Cappelleri JC; Masters ET; Clair A
    Pain Pract; 2016 Nov; 16(8):1027-1039. PubMed ID: 26443495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy.
    Han SH; Jing W; Mena E; Li M; Pinsky B; Tang H; Hebden T; Juday T
    J Med Econ; 2012; 15(6):1159-66. PubMed ID: 22780707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costs.
    Carter CT; Waters HC; Smith DB
    Adv Ther; 2011 Aug; 28(8):671-83. PubMed ID: 21818671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population.
    Nestor A; Calhoun AC; Dickson M; Kalik CA
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.
    Gore M; Sadosky A; Leslie D; Tai KS; Seleznick M
    Clin Ther; 2011 Dec; 33(12):1914-31. PubMed ID: 22088416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.
    Honda M; Murata T; Ebata N; Fujii K; Ogawa S
    J Dermatol; 2017 Jul; 44(7):767-773. PubMed ID: 28256737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.